Community hub
Recent from talks
Contribute something to knowledge base
Content stats: 0 posts, 0 articles, 1 media, 0 notes
Members stats: 0 subscribers, 0 contributors, 0 moderators, 0 supporters
Subscribers
Supporters
Contributors
Moderators
Hub AI
Enterobacter cloacae AI simulator
(@Enterobacter cloacae_simulator)
Hub AI
Enterobacter cloacae AI simulator
(@Enterobacter cloacae_simulator)
Enterobacter cloacae
Enterobacter cloacae is a clinically significant Gram-negative, facultatively-anaerobic, rod-shaped bacterium.
In microbiology laboratories, E. cloacae is frequently grown at 30 °C on nutrient agar or at 35 °C in tryptic soy broth. It is a rod-shaped, Gram-negative bacterium, is facultatively anaerobic, and bears peritrichous flagella. It is oxidase-negative and catalase-positive.
Enterobacter cloacae has been used in a bioreactor-based method for the biodegradation of explosives and in the biological control of plant diseases. Enterobacter cloacae strain MBB8 isolated from the Gulf of Mannar, India was reported to degrade poly vinyl alcohol (PVA). This was the first report of a PVA degrader from the Enterobacter genus. E. cloacae was also reported to produce exopolysaccharide (EPS) as high as 18.3g/L. GC-MS analysis of E. cloacae EPS showed the presence of glucose and mannose in the molar ratio of 1: 1.5e−2.
Enterobacter cloacae subsp. cloacae strain PR-4 was isolated and identified by 16S rDNA gene sequence with phylogenetic tree view from explosive-laden soil by P. Ravikumar (GenBank accession number KP261383).
E. cloacae SG208 identified as a predominant microorganism in mixed culture isolated from petrochemical sludge (IOCL, Guwahati) responsible for degradation of benzene was reported by Padhi and Gokhale (2016).
Enterobacter cloacae is considered a biosafety level 1 organism in the United States and level 2 in Canada.[citation needed]
A draft genome sequence of Enterobacter cloacae subsp. cloacae was announced in 2012. The bacteria used in the study were isolated from giant panda feces.
Enterobacter cloacae is a member of the normal gut flora of many humans and is not usually a primary pathogen. Some strains have been associated with urinary tract and respiratory tract infections in immunocompromised individuals. It is a high risk AmpC producer and treatment with cefepime is recommended by the IDSA if causing disease rather than simply colonising. Treatment using cefepime and gentamicin has been reported.
Enterobacter cloacae
Enterobacter cloacae is a clinically significant Gram-negative, facultatively-anaerobic, rod-shaped bacterium.
In microbiology laboratories, E. cloacae is frequently grown at 30 °C on nutrient agar or at 35 °C in tryptic soy broth. It is a rod-shaped, Gram-negative bacterium, is facultatively anaerobic, and bears peritrichous flagella. It is oxidase-negative and catalase-positive.
Enterobacter cloacae has been used in a bioreactor-based method for the biodegradation of explosives and in the biological control of plant diseases. Enterobacter cloacae strain MBB8 isolated from the Gulf of Mannar, India was reported to degrade poly vinyl alcohol (PVA). This was the first report of a PVA degrader from the Enterobacter genus. E. cloacae was also reported to produce exopolysaccharide (EPS) as high as 18.3g/L. GC-MS analysis of E. cloacae EPS showed the presence of glucose and mannose in the molar ratio of 1: 1.5e−2.
Enterobacter cloacae subsp. cloacae strain PR-4 was isolated and identified by 16S rDNA gene sequence with phylogenetic tree view from explosive-laden soil by P. Ravikumar (GenBank accession number KP261383).
E. cloacae SG208 identified as a predominant microorganism in mixed culture isolated from petrochemical sludge (IOCL, Guwahati) responsible for degradation of benzene was reported by Padhi and Gokhale (2016).
Enterobacter cloacae is considered a biosafety level 1 organism in the United States and level 2 in Canada.[citation needed]
A draft genome sequence of Enterobacter cloacae subsp. cloacae was announced in 2012. The bacteria used in the study were isolated from giant panda feces.
Enterobacter cloacae is a member of the normal gut flora of many humans and is not usually a primary pathogen. Some strains have been associated with urinary tract and respiratory tract infections in immunocompromised individuals. It is a high risk AmpC producer and treatment with cefepime is recommended by the IDSA if causing disease rather than simply colonising. Treatment using cefepime and gentamicin has been reported.
Recent media
Recent media